A 68 year old female is admitted to the medical intensive care unit from the nursing home for septic shock likely due to pneumonia. The patient has NKDA and is written for vancomycin, piperacillin/tazobactam, and tobramycin for empiric therapy. Which of the following antibiotics that she is receiving exerts its mechanism of action by inhibiting cell wall synthesis?
A. Vancomycin and piperacillin/tazobactam
B. Piperacillin/tazobactam and tobramycin
C. Vancomycin and tobramycin
Answer with rationale:
The correct answer is A. All beta-lactams, carbapenems, and monobactams (remember aztreonam?) decrease cell wall synthesis leading to cell death in the bacteria targeted. Remember that beta-lactams include penicillins and cephalosporins. Vancomycin works by binding to the D-alanyl-D-alanine terminal of the growing peptide chain during cell wall synthesis, resulting in inhibition of transpeptidase, which prevents further elongation and cross-linking of the peptidoglycan matrix. Aminoglycosides such as tobramycin work to inhibit protein synthesis by irreversible binding to the 30S ribosomal subunit making answers B, C, and E incorrect.
Mechanisms of action are crucial to foundational knowledge to understand clinical pharmacotherapy. By understanding mechanism of action, you further solidify pathophysiology by understanding drug targets for disease and don't "memorize" material. Knowledge of mechanisms of action falls into NAPLEX competency statement 1.2.5.
Have a great week!